These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6775094)
41. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints. Cullberg G; Knutsson F; Mattsson LA Maturitas; 1984 Jul; 6(1):55-63. PubMed ID: 6088950 [TBL] [Abstract][Full Text] [Related]
42. [Clinical effects of metharmon F for postmenopausal women with climacteric symptoms: its relationship with serum level of hormones]. Yoshimoto S; Fujita T Horumon To Rinsho; 1983 Aug; 31(8):815-22. PubMed ID: 6414748 [No Abstract] [Full Text] [Related]
43. The menopause. Brenner PF West J Med; 1982 Mar; 136(3):211-9. PubMed ID: 7090370 [TBL] [Abstract][Full Text] [Related]
44. Plasma levels of estrogen, luteinizing hormone, and follicle stimulating hormone following castration and estradiol implant. Hunter DJ; Julier D; Franklin M; Green E Obstet Gynecol; 1977 Feb; 49(2):180-5. PubMed ID: 834401 [TBL] [Abstract][Full Text] [Related]
50. Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flushes in the surgical menopause. Sherwin BB; Gelfand MM Am J Obstet Gynecol; 1984 Mar; 148(5):552-7. PubMed ID: 6367474 [TBL] [Abstract][Full Text] [Related]
51. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800 [TBL] [Abstract][Full Text] [Related]
52. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790 [TBL] [Abstract][Full Text] [Related]
53. Maintenance of sexual function in a castrated man treated with ovarian steroids. Davidson JM; Camargo C; Smith ER; Kwan M Arch Sex Behav; 1983 Jun; 12(3):263-74. PubMed ID: 6309119 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of progestational agents for postmenopausal hot flushes. Roopnarinesingh S Int J Gynaecol Obstet; 1982 Apr; 20(2):133-5. PubMed ID: 6125433 [No Abstract] [Full Text] [Related]
55. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol. Jaschevatzky OE; Anderman S; Shalit A; Kampf D; Grünstein S Acta Obstet Gynecol Scand; 1979; 58(2):175-8. PubMed ID: 452871 [TBL] [Abstract][Full Text] [Related]
56. Circadian pattern of prolactin secretion in postmenopausal women receiving estrogen with or without progestin. Chang RJ; Davidson BJ; Carlson HE; Judd HL Am J Obstet Gynecol; 1982 Oct; 144(4):402-7. PubMed ID: 7124858 [TBL] [Abstract][Full Text] [Related]
57. Veralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled study. Vercellini P; Sacerdote P; Trespidi L; Manfredi B; Panerai AE; Crosignani PG Fertil Steril; 1994 Nov; 62(5):938-42. PubMed ID: 7926138 [TBL] [Abstract][Full Text] [Related]
58. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma. Charig CR; Rundle JS Urology; 1989 Mar; 33(3):175-8. PubMed ID: 2465644 [TBL] [Abstract][Full Text] [Related]
59. Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy. Barlow DH; Beastall GH; Abdalla HI; Elias-Jones J; Lindsay R; Hart DM Br Med J (Clin Res Ed); 1985 Feb; 290(6468):589-91. PubMed ID: 3918684 [TBL] [Abstract][Full Text] [Related]
60. [The alternative to hormonal treatment of menopausal vasomotor flushes: veralipride]. Wesel S; Bosuma WB Sem Hop; 1983 Mar; 59(9):596-9. PubMed ID: 6304907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]